Guanhao BiotechLtd Valuation

Q: What is the Fair Price of 300238 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

300238 (CN¥12.97) is trading above our estimate of [[fair value]] (CN¥0.1)

Is 300238 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 300238 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300238 (CN¥12.97) is trading above our estimate of fair value (CN¥0.1)

Significantly Below Fair Value: 300238 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300238?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 300238. This is calculated by dividing 300238's market cap by their current preferred multiple.
What is 300238's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥3.44b

300238 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	8.7x
Enterprise Value/EBITDA	76.4x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 300238's PS Ratio compare to its peers?

The above table shows the PS ratio for 300238 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	8.9x
000710 Berry GenomicsLtd	2.7x	n/a	CN¥3.1b
300149 ChemPartner PharmaTechLtd	3.3x	n/a	CN¥3.5b
000504 Landfar Bio-medicine	22.8x	n/a	CN¥2.8b
300289 Beijing Leadman BiochemistryLtd	6.7x	n/a	CN¥2.8b
300238 Guanhao BiotechLtd	9x	n/a	CN¥3.4b

Price-To-Sales vs Peers: 300238 is expensive based on its Price-To-Sales Ratio (9x) compared to the peer average (8.9x).

Price to Earnings Ratio vs Industry

How does 300238's PE Ratio compare vs other companies in the CN Biotechs Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	38.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	38.4%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: 300238 is expensive based on its Price-To-Sales Ratio (9x) compared to the CN Biotechs industry average (7x).

Price to Sales Ratio vs Fair Ratio

What is 300238's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300238 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	9x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 300238's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.